Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'John, GW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Letienne, R; Vie, B; Puech, A; Vieu, S; Le Grand, B; John, GW
      Evidence that ranolazine behaves as a weak beta(1)- and beta(2)-adrenoceptor antagonist in the rat cardiovascular system

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    2. Le Grand, B; Dordain-Maffre, M; John, GW
      Lubeluzole-induced prolongation of cardiac action potential in rabbit Purkinje fibres

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    3. Le Grand, B; Panissie, A; Perez, M; Pauwels, PJ; John, GW
      Zolmitriptan stimulates a Ca2+-dependent K+ current in C6 glioma cells stably expressing recombinant human 5-HT1B receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Pauwels, PJ; John, GW
      Present and future of 5-HT receptor agonists as antimigraine drugs

      CLINICAL NEUROPHARMACOLOGY
    5. John, GW; Pauwels, PJ; Perez, M; Halazy, S; Le Grand, B; Verscheure, Y; Valentin, JP; Palmier, C; Wurch, T; Chopin, P; Marien, M; Kleven, MS; Koek, W; Assie, MB; Carilla-Durand, E; Tarayre, JP; Colpaert, FC
      F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. PEREZ M; PAUWELS PJ; FOURRIER C; CHOPIN P; VALENTIN JP; JOHN GW; MARIEN M; HALAZY S
      DIMERIZATION OF SUMATRIPTAN AS AN EFFICIENT WAY TO DESIGN A POTENT, CENTRALLY AND ORALLY-ACTIVE 5-HT1B AGONIST

      Bioorganic & medicinal chemistry letters
    7. VALENTIN JP; BONNAFOUS R; JOHN GW
      CONTRACTILE RESPONSES EVOKED BY DIHYDROERGOTAMINE, NARATRIPTAN AND SUMATRIPTAN IN THE CANINE ISOLATED CORONARY-ARTERY

      Fundamental and clinical pharmacology
    8. LEGRAND B; VIE B; JOHN GW
      EFFECTS OF SUMATRIPTAN ON CORONARY FLOW AND LEFT-VENTRICULAR FUNCTIONIN THE ISOLATED-PERFUSED GUINEA-PIG HEART

      Journal of cardiovascular pharmacology
    9. LEGRAND B; COULOMBE A; JOHN GW
      LATE SODIUM CURRENT INHIBITION IN HUMAN ISOLATED CARDIOMYOCYTES BY R-56865

      Journal of cardiovascular pharmacology
    10. LEGRAND B; DUROSIER E; RIEU JP; PATOISEAU JF; JOHN GW
      INTERACTION OF LUBELUZOLE WITH CARDIAC SODIUM-CHANNELS

      Naunyn-Schmiedeberg's archives of pharmacology
    11. JOHN GW; VERSCHEURE Y; INFANTI F; BEL L; PEREZ M; HALAZY S; CHOPIN P; MARIEN M; COLPAERT FC
      IN-VIVO PHARMACOLOGICAL ACTIONS OF F-11356, A NOVEL HIGH EFFICACY ANTIMIGRAINE 5-HT1B D RECEPTOR AGONIST/

      Naunyn-Schmiedeberg's archives of pharmacology
    12. JOHN GW; VALENTIN JP; LEGRAND B; BONNAFOUS R; PANISSIE A; VIE B; PEREZ M; HALAZY S; PAUWELS PJ; COLPAERT FC
      IN-VITRO VASCULAR AND NEURONAL ACTIONS OF F-11356, A NOVEL HIGH EFFICACY 5HT(1B D) RECEPTOR AGONIST, IN MODELS RELEVANT TO MIGRAINE/

      Naunyn-Schmiedeberg's archives of pharmacology
    13. PAUWELS PJ; PALMIER C; TARDIF S; WURCH T; PEREZ M; CARILLADURAND E; JOHN GW; HALAZY S; COLPAERT FC
      F-11356, A NEW 5-HT DERIVATIVE, WITH SELECTIVE, POTENT AND HIGH EFFICACY AGONIST PROPERTIES AT 5-HT1B D RECEPTORS/

      Naunyn-Schmiedeberg's archives of pharmacology
    14. Le Grand, B; Panissie, A; Pauwels, PJ; John, GW
      Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressedin C6 glioma cells produces increases in Ca2+-dependent K+ current

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    15. PAGNIEZ F; VALENTIN JP; VIEU S; COLPAERT FC; JOHN GW
      PHARMACOLOGICAL ANALYSIS OF THE HEMODYNAMIC-EFFECTS OF 5-HT1B D RECEPTOR AGONISTS IN THE NORMOTENSIVE RAT/

      British Journal of Pharmacology
    16. VALENTIN JP; JOVER B; MAFFRE M; BERTOLINO F; BESSAC AM; JOHN GW
      LOSARTAN PREVENTS THROMBOXANE A(2) PROSTANOID (TP) RECEPTOR-MEDIATED INCREASE IN MICROVASCULAR PERMEABILITY IN THE RAT

      American journal of hypertension
    17. PEREZ M; AYERBE N; FOURRIER C; SIGOGNEAU I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      SYNTHESIS, BINDING-AFFINITY AND INTRINSIC ACTIVITY OF NEW ANILIDE DERIVATIVES OF SEROTONIN AT HUMAN 5-HT1D RECEPTORS

      European journal of medicinal chemistry
    18. BERTOLINO F; VALENTIN JP; PATOISEAU JF; RIEU JP; COLPAERT FC; JOHN GW
      EVIDENCE FOR PARTIAL AGONIST PROPERTIES OF DALTROBAN (BM-13,505) AT TP RECEPTORS IN THE ANESTHETIZED OPEN-CHEST RAT

      Naunyn-Schmiedeberg's archives of pharmacology
    19. VALENTIN JP; VIEU S; BERTOLINO F; FAURE P; JOHN GW
      DIFFERENTIAL INVOLVEMENT OF SEROTONIN 2A C AND THROMBOXANE-A(2)/PROSTANOID RECEPTORS IN HIGH-SHEAR VS LOW-SHEAR RATE ARTERIAL THROMBOSIS INRABBITS/

      The Journal of pharmacology and experimental therapeutics
    20. JOHN GW; VALENTIN JP
      ANALYSIS OF THE PULMONARY HYPERTENSIVE EFFECTS OF THE ISOPROSTANE DERIVATIVE, 8-ISO-PGF(2-ALPHA), IN THE RAT

      British Journal of Pharmacology
    21. VALENTIN JP; BONNAFOUS R; JOHN GW
      MODULATION BY THE ENDOTHELIUM OF CONTRACTILE RESPONSES EVOKED BY 5-HT1B D RECEPTOR AGONISTS IN THE RABBIT ISOLATED SAPHENOUS-VEIN/

      British Journal of Pharmacology
    22. PAGNIEZ F; VALENTIN JP; VIEU S; JOHN GW
      ANALYSIS OF THE HEMODYNAMIC-EFFECTS OF 5-HT1B D RECEPTOR AGONISTS IN THE RAT/

      British Journal of Pharmacology
    23. LEGRAND B; PAUWELS PJ; PANISSIE A; JOHN GW
      RECOMBINANT H5-HT1B AND H5-HT1D RECEPTORS STABLY EXPRESSED IN C6 GLIOMA-CELLS ARE COUPLED TO CALCIUM-DEPENDENT POTASSIUM CHANNELS

      British Journal of Pharmacology
    24. LEGRAND B; VIE B; JOHN GW
      EFFECTS OF 5-HT1B D RECEPTOR AGONISTS ON FUNCTION IN THE GUINEA-PIG ISOLATED-PERFUSED HEART/

      British Journal of Pharmacology
    25. JOHN GW; CAUSSE C
      NITRATE DERIVATIVES HAVENT SAID THEIR LAS T WORD

      Annales de cardiologie et d'angeiologie
    26. WURCH T; CATHALA C; PALMIER C; VALENTIN JP; JOHN GW; COLPAERT FC; PAUWELS PJ
      MOLECULAR-CLONING AND IDENTIFICATION OF A RABBIT SAPHENOUS-VEIN 5-HT1D-BETA RECEPTOR GENE

      Neuroscience research communications
    27. LEGRAND B; MARTY A; TALMANT JM; JOHN GW
      HOE-694 AFFORDS PROTECTION VERSUS VERATRINE CONTRACTURES IN RAT ATRIABY NA+ CHANNEL BLOCKADE

      Fundamental and clinical pharmacology
    28. HALAZY S; PEREZ M; FOURRIER C; PALLARD I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; BONNAFOUS R; MARTINEZ J
      SEROTONIN DIMERS - APPLICATION OF THE BIVALENT LIGAND APPROACH TO THEDESIGN OF NEW POTENT AND SELECTIVE 5-HT1B 1D AGONISTS/

      Journal of medicinal chemistry
    29. VALENTIN JP; BESSAC AM; MAFFRE M; JOHN GW
      NITRIC-OXIDE REGULATION OF TP RECEPTOR-MEDIATED PULMONARY VASOCONSTRICTION IN THE ANESTHETIZED, OPEN-CHEST RAT

      European journal of pharmacology
    30. VALENTIN JP; BONNAFOUS R; JOHN GW
      INFLUENCE OF THE ENDOTHELIUM AND NITRIC-OXIDE ON THE CONTRACTILE RESPONSES EVOKED BY 5-HT1D RECEPTOR AGONISTS IN THE RABBIT ISOLATED SAPHENOUS-VEIN

      British Journal of Pharmacology
    31. PEREZ M; PAUWELS P; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      5-O-CARBOXYMETHYL PIPERAZIDE DERIVATIVES OF SEROTONIN - A NEW CLASS OF POTENT AND SELECTIVE 5-HT1D RECEPTOR AGONISTS

      Bioorganic & medicinal chemistry letters
    32. VALENTIN JP; BESSAC AM; COLPAERT FC; JOHN GW
      USE OF THE PITHED RAT MODEL TO DETERMINE THE RELATIVE POTENCIES OF 5-HT2A 2C RECEPTOR ANTAGONISTS FOLLOWING ACUTE INTRAVENOUS AND ORAL-ADMINISTRATION/

      Methods and findings in experimental and clinical pharmacology
    33. LEGRAND B; VIE B; TALMANT JM; CORABOEUF E; JOHN GW
      ALLEVIATION OF CONTRACTILE DYSFUNCTION IN ISCHEMIC HEARTS BY SLOWLY INACTIVATING NA+ CURRENT BLOCKERS

      American journal of physiology. Heart and circulatory physiology
    34. BERTOLINO F; VALENTIN JP; MAFFRE M; BESSAC AM; JOHN GW
      TXA(2) RECEPTOR ACTIVATION ELICITS ORGAN-SPECIFIC INCREASES IN MICROVASCULAR PERMEABILITY IN THE RAT

      American journal of physiology. Regulatory, integrative and comparative physiology
    35. LEGRAND B; TALMANT JM; RIEU JP; PATOISEAU JF; COLPAERT FC; JOHN GW
      INVESTIGATION OF THE MECHANISM BY WHICH KETANSERIN PROLONGS THE DURATION OF THE CARDIAC ACTION-POTENTIAL

      Journal of cardiovascular pharmacology
    36. LEGRAND B; MARTY A; COLPAERT FC; JOHN GW
      KETANSERIN INHIBITS THE TRANSIENT OUTWARD CURRENT IN RABBIT VENTRICULAR MYOCYTES

      Journal of cardiovascular pharmacology
    37. VERSCHEURE Y; POUGET G; DECOURTOIS F; LEGRAND B; JOHN GW
      ATTENUATION BY R-56865, A NOVEL CYTOPROTECTIVE DRUG, OF REGIONAL MYOCARDIAL ISCHEMIA-INDUCED AND REPERFUSION-INDUCED ELECTROCARDIOGRAPHIC DISTURBANCES IN ANESTHETIZED RABBITS

      Journal of cardiovascular pharmacology
    38. PEREZ M; FOURRIER C; SIGOGNEAU I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF ARYLPIPERAZIDE DERIVATIVES OF SEROTONIN - POTENT AGONISTS FOR 5-HT1D RECEPTORS

      Journal of medicinal chemistry
    39. VERSCHEURE Y; POUGET G; DECOURTOIS F; PANISSIE A; LEGRAND B; JOHN GW
      INVOLVEMENT OF THE LATE SODIUM CURRENT (INAL) IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN THE ANESTHETIZED RABBIT

      Circulation
    40. BERTOLINO F; VALENTIN JP; VIEU S; JOHN GW
      DIFFERENTIAL INVOLVEMENT OF SEROTONIN 2A C AND THROMBOXANE A2 RECEPTORS IN HIGH VERSUS LOW SHEAR RATE ARTERIAL THROMBOSIS IN THE RABBIT/

      Circulation
    41. LEGRAND B; VIE B; FAURE P; DEGRYSE AD; MOUILLARD P; JOHN GW
      INCREASED RESISTANCE TO ISCHEMIC-INJURY IN THE ISOLATED-PERFUSED ATHEROSCLEROTIC HEART OF THE CHOLESTEROL-FED RABBIT

      Cardiovascular Research
    42. BERTOLINO F; VALENTIN JP; MAFFRE M; GRELAC F; BESSAC AM; MACLOUF J; DELHON A; LEVYTOLEDANO S; PATOISEAU JF; COLPAERT FC; JOHN GW
      INTRINSIC ACTIVITY OF THE NONPROSTANOID THROMBOXANE A(2) RECEPTOR ANTAGONIST, DALTROBAN (BM-13,505), IN HUMAN PLATELETS IN-VITRO AND IN THERAT VASCULATURE IN-VIVO

      British Journal of Pharmacology
    43. BERTOLINO F; VALENTIN JP; MAFFRE M; JOVER B; BESSAC AM; JOHN GW
      PREVENTION OF THROMBOXANE A(2) RECEPTOR-MEDIATED PULMONARY-HYPERTENSION BY A NONPEPTIDE ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    44. LEGRAND B; MARTY A; VIE B; PATOISEAU JF; JOHN GW
      PREVENTION BY SPECIFIC CHEMICAL CLASSES OF ALPHA(1)-ADRENOCEPTOR ANTAGONISTS OF VERATRINE-CONTRACTURES IN RAT LEFT ATRIA INDEPENDENTLY OF ALPHA(1)-ADRENOCEPTOR BLOCKADE

      British Journal of Pharmacology
    45. BERTOLINO F; VALENTIN JP; MAFFRE M; JOVER B; BESSAC AM; JOHN GW
      LOSARTAN PREVENTS THROMBOXANE-A(2) RECEPT OR-MEDIATED PULMONARY-HYPERTENSION

      Archives des maladies du coeur et des vaisseaux
    46. JOHN GW; SHRIVASTAVA R; CHEVALIER A; POGNAT JF; MASSINGHAM R
      AN INVITRO INVESTIGATION OF THE RELATIONSHIPS BETWEEN POTENCY, LIPOPHILICITY, CYTOTOXICITY AND CHEMICAL CLASS OF REPRESENTATIVE CALCIUM-ANTAGONIST DRUGS

      Pharmacological research
    47. VALENTIN JP; BERTOLINO F; MAFFRE M; JOVER B; BESSAC AM; JOHN GW
      PREVENTION OF THROMBOXANE-A2 (TXA2) RECEPTOR-MEDIATED PULMONARY-HYPERTENSION AND PLASMA EXUDATION BY A NONPEPTIDE ANGIOTENSIN-II TYPE-1 (AT1) RECEPTOR ANTAGONIST

      Hypertension
    48. LEGRAND B; MARTY A; VIEU S; TALMANT JM; JOHN GW
      VERATRINE-INDUCED TETANIC CONTRACTURE OF THE RAT ISOLATED LEFT ATRIUM- EVIDENCE FOR NOVEL DIRECT PROTECTIVE EFFECTS OF PRAZOSIN AND WB-4101

      Naunyn-Schmiedeberg's archives of pharmacology
    49. BERTOLINO F; VALENTIN JP; MAFFRE M; BESSAC AM; JOHN GW
      THROMBOXANE-A2 (TXA2) RECEPTOR ACTIVATION ELICITS ORGAN-SPECIFIC INCREASES IN TRANSCAPILLARY SHIFT OF FLUID AND PROTEINS IN THE RAT

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 22:11:15